The relationship of neurocognition and negative symptoms to social and role functioning over time in individuals at clinical high risk in the first phase of the north american prodrome longitudinal study

Schizophrenia Bulletin

Volumn 40, Issue 6, 2014, Pages 1452-1461

  Meyer, Eric C ^a,b   Carrión, Ricardo E ^c   Cornblatt, Barbara A ^c   Addington, Jean ^d   Cadenhead, Kristin S ^e   Cannon, Tyrone D ^f,g   McGlashan, Thomas H ^g   Perkins, Diana O ^h   Tsuang, Ming T ^e,i   Walker, Elaine F ^j   Woods, Scott W ^g   Heinssen, Robert ^k   Seidman, Larry J ^l,m,n  

^a VA VISN 17 Center of Excellence for Research on Returning War Veterans   (United States)

^b TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^c ZUCKER HILLSIDE HOSPITAL   (United States)

^d UNIVERSITY OF CALGARY   (Canada)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j EMORY UNIVERSITY   (United States)

^k NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^l BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^m MASSACHUSETTS GENERAL HOSPITAL   (United States)

ⁿ MASSACHUSETTS MENTAL HEALTH CENTER   (United States)

more..

Author keywords

negative symptoms; neurocognition; prodrome; social and role functioning

Indexed keywords

ADULT; ARTICLE; CHILD; COGNITION; FEMALE; FOLLOW UP; HUMAN; INTELLIGENCE QUOTIENT; LONGITUDINAL STUDY; MALE; NEGATIVE SYNDROME; NEUROCOGNITION; POSITIVE SYNDROME; ROLE FUNCTIONING; SOCIAL INTERACTION; VERBAL MEMORY; ADOLESCENT; COGNITION DISORDERS; COMPLICATION; DISEASE COURSE; PATHOPHYSIOLOGY; PRODROMAL SYMPTOM; PSYCHOSIS; ROLE PLAYING; SOCIAL ADAPTATION; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; COGNITION DISORDERS; DISEASE PROGRESSION; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; PRODROMAL SYMPTOMS; PSYCHOTIC DISORDERS; ROLE; SOCIAL SKILLS; YOUNG ADULT;

EID: 84913554480     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbt235     Document Type: Article

References (48)

1. Nelson B, Yuen HP, Wood SJ, et al. Long-term follow-up of a group at ultra high risk ("prodromal") for psychosis: the PACE 400 study. JAMA Psychiatry. 2013;70:793-802.
2. Ruhrmann S, Schultze-Lutter F, Salokangas RK, et al. Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis study. Arch Gen Psychiatry. 2010;67:241-251.
3. Cannon TD, Cadenhead K, Cornblatt B, et al. Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Arch Gen Psychiatry. 2008;65:28-37.
4. Cornblatt BA, Lencz T, Smith CW, Correll CU, Auther AM, Nakayama E. The schizophrenia prodrome revisited: a neurodevelopmental perspective. Schizophr Bull. 2003;29:633-651.
5. Cornblatt BA, Carrión RE, Addington J, et al. Risk factors for psychosis: impaired social and role functioning. Schizophr Bull. 2012;38:1247-1257.
6. Seidman LJ, Giuliano AJ, Meyer EC, et al.; North American Prodrome Longitudinal Study (NAPLS) Group. Neuropsychology of the prodrome to psychosis in the NAPLS consortium: relationship to family history and conversion to psychosis. Arch Gen Psychiatry. 2010;67:578-588.
7. Seidman LJ, Cherkerzian S, Goldstein JM, Agnew-Blais J, Tsuang MT, Buka SL. Neuropsychological performance and family history in children at age 7 who develop adult schizophrenia or bipolar psychosis in the New England Family Studies. Psychol Med. 2013;43:119-131.
8. Tarbox SI, Pogue-Geile MF. Development of social functioning in preschizophrenia children and adolescents: a systematic review. Psychol Bull. 2008;134:561-583.
9. Woodberry KA, Giuliano AJ, Seidman LJ. Premorbid IQ in schizophrenia: a meta-analytic review. Am J Psychiatry. 2008;165:579-587.
10. Giuliano AJ, Li H, Mesholam-Gately RI, Sorenson SM, Woodberry KA, Seidman LJ. Neurocognition in the psychosis risk syndrome: a quantitative and qualitative review. Curr Pharm Des. 2012;18:399-415.
11. Fusar-Poli P, Deste G, Smieskova R, et al. Cognitive functioning in prodromal psychosis: a meta-analysis. Arch Gen Psychiatry. 2012;69:562-571.
12. Piskulic D, Addington J, Cadenhead KS, et al. Negative symptoms in individuals at clinical high risk of psychosis. Psychiatry Res. 2012;196:220-224.
13. Lin A, Wood SJ, Nelson B, et al. Neurocognitive predictors of functional outcome two to 13 years after identification as ultra-high risk for psychosis. Schizophr Res. 2011;132:1-7.
14. Salokangas RK, Nieman DH, Heinimaa M, et al.; EPOS group. Psychosocial outcome in patients at clinical high risk of psychosis: a prospective follow-up. Soc Psychiatry Psychiatr Epidemiol. 2013;48:303-311.
15. Addington J, Cornblatt BA, Cadenhead KS, et al. At clinical high risk for psychosis: outcome for nonconverters. Am J Psychiatry. 2011;168:800-805.
16. Ventura J, Hellemann GS, Thames AD, Koellner V, Nuechterlein KH. Symptoms as mediators of the relationship between neurocognition and functional outcome in schizophrenia: a meta-analysis. Schizophr Res. 2009;113:189-199.
17. Green MF. What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry. 1996;153:321-330.
18. Nuechterlein KH, Subotnik KL, Green MF, et al. Neurocognitive predictors of work outcome in recent-onset schizophrenia. Schizophr Bull. 2011;37(suppl 2):S33-S40; doi:10.1093/schbul/sbr084.
19. Tandberg M, Ueland T, Sundet K, et al. Neurocognition and occupational functioning in patients with first-episode psychosis: a 2-year follow-up study. Psychiatry Res. 2011;188:334-342.
20. Malla AK, Norman RM, Manchanda R, Townsend L. Symptoms, cognition, treatment adherence and functional outcome in first-episode psychosis. Psychol Med. 2002;32:1109-1119.
21. Allott K, Liu P, Proffitt TM, Killackey E. Cognition at illness onset as a predictor of later functional outcome in early psychosis: systematic review and methodological critique. Schizophr Res. 2011;125:221-235.
22. Vesterager J, Christensen TO, Olsen BB, et al. Cognitive and clinical predictors of functional capacity in patients with first episode schizophrenia. Schizophr Res. 2012;141:251-256.
23. Harvey PD, Silverman JM, Mohs RC, et al. Cognitive decline in late-life schizophrenia: a longitudinal study of geriatric chronically hospitalized patients. Biol Psychiatry. 1999;45:32-40.
24. Puig O, Penadés R, Gastó C, Catalán R, Torres A, Salamero M. Verbal memory, negative symptomatology and prediction of psychosocial functioning in schizophrenia. Psychiatry Res. 2008;158:11-17.
25. Harvey PD, Koren D, Reichenberg A, Bowie CR. Negative symptoms and cognitive deficits: what is the nature of their relationship? Schizophr Bull. 2006;32:250-258.
26. Kirkpatrick B, Fenton WS, Carpenter WT Jr, Marder S.R. The NIMH-MATRICS consensus statement on negative symptoms. Schizophr Bull. 2006;32:214-219.
27. Bilder RM, Goldman RS, Robinson D, et al. Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates. Am J Psychiatry. 2000;157:549-559.
28. Heydebrand G, Weiser M, Rabinowitz J, Hoff AL, DeLisi LE, Csernansky JG. Correlates of cognitive deficits in first episode schizophrenia. Schizophr Res. 2004;68:1-9.
29. Addington J, Saeedi H, Addington D. The course of cognitive functioning in first episode psychosis: changes over time and impact on outcome. Schizophr Res. 2005;78:35-43.
30. Carlsson R, Nyman H, Ganse G, Cullberg J. Neuropsychological functions predict 1- and 3-year outcome in first-episode psychosis. Acta Psychiatr Scand. 2006;113:102-111.
31. Lindsberg J, Poutiainen E, Kalska H. Clarifying the diversity of first-episode psychosis: neuropsychological correlates of clinical symptoms. Nord J Psychiatry. 2009;63:493-500.
32. Leeson VC, Barnes TR, Harrison M, et al. The relationship between IQ, memory, executive function, and processing speed in recent-onset psychosis: 1-year stability and clinical outcome. Schizophr Bull. 2010;36:400-409.
33. Dominguez Mde G, Viechtbauer W, Simons CJ, van Os J, Krabbendam L. Are psychotic psychopathology and neurocognition orthogonal? A systematic review of their associations. Psychol Bull. 2009;135:157-171.
34. Galderisi S, Davidson M, Kahn RS, et al.; EUFEST group. Correlates of cognitive impairment in first episode schizophrenia: the EUFEST study. Schizophr Res. 2009;115:104-114.
35. Eslami A, Jahshan C, Cadenhead KS. Disorganized symptoms and executive functioning predict impaired social functioning in subjects at risk for psychosis. J Neuropsychiatry Clin Neurosci. 2011;23:457-460.
36. Niendam TA, Bearden CE, Zinberg J, Johnson JK, O'Brien M, Cannon TD. The course of neurocognition and social functioning in individuals at ultra high risk for psychosis. Schizophr Bull. 2007;33:772-781.
37. Carrión RE, Goldberg TE, McLaughlin D, Auther AM, Correll CU, Cornblatt BA. Impact of neurocognition on social and role functioning in individuals at clinical high risk for psychosis. Am J Psychiatry. 2011;168:806-813.
38. Carrión RE, McLaughlin D, Goldberg TE, et al. Prediction of functional outcome in individuals at clinical high risk for psychosis. JAMA Psychiatry. 2013;70:1133-1142.
39. Miller TJ, McGlashan TH, Rosen JL, et al. Prodromal assessment with the Structured Interview for Prodromal Syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability. Schizophr Bull. 2003;29:703-715.
40. Cornblatt BA, Auther AM, Niendam T, et al. Preliminary findings for two new measures of social and role functioning in the prodromal phase of schizophrenia. Schizophr Bull. 2007;33:688-702.
41. Preacher KJ, Hayes AF. SPSS and SAS procedures for estimating indirect effects in simple mediation models. Behav Res Methods Instrum Comput. 2004;36:717-731.
42. Green MF, Kern RS, Braff DL, Mintz J. Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff "? Schizophr Bull. 2000;26:119-136.
43. Schmidt SJ, Mueller DR, Roder V. Social cognition as a mediator variable between neurocognition and functional outcome in schizophrenia: empirical review and new results by structural equation modeling. Schizophr Bull. 2011;37(suppl 2):S41-S54.
44. Dickinson D, Iannone VN, Wilk CM, Gold JM. General and specific cognitive deficits in schizophrenia. Biol Psychiatry. 2004;55:826-833.
45. Addington J, Cadenhead KS, Cornblatt BA, et al. North American Prodrome Longitudinal Study (NAPLS 2): overview and recruitment. Schizophr Res. 2012;142:77-82.
46. Holshausen K, Bowie CR, Mausbach BT, Patterson TL, Harvey PD. Neurocognition, functional capacity, and functional outcomes: the cost of inexperience. [Epub ahead of print]. Schizophr Res. 2013; doi:10.1016/j. schres.2013.08.004.
47. Green MF, Hellemann G, Horan WP, Lee J, Wynn JK. From perception to functional outcome in schizophrenia: modeling the role of ability and motivation. Arch Gen Psychiatry. 2012;69:1216-1224.
48. Preti A, Cella M. Randomized-controlled trials in people at ultra high risk of psychosis: a review of treatment effectiveness. Schizophr Res. 2010;123:30-36.